Close Menu

Oops, Fake-Out

Merck published a journal containing reprinted or review articles that reported data favorable to the drug company, all without disclosing its sponsorship of the journal, says The Scientist. The journal, called the Australasian Journal of Bone and Joint Medicine, was published by a division of Elsevier, to which Merck paid an undisclosed sum, the article says. "To the jaundiced eye, [the journal] might be detected for what it is: marketing," Public Citizen's Peter Lurie says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.